查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1673877

基因组工程市场：按技术、应用、最终用户和地区划分

Genome Engineering Market, By Technology, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 185 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球基因组工程市场规模估计为 77 亿美元，预计到 2032 年将达到 201.2 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 14.7%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 77亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 14.70％ 2032 年金额预测 201.2亿美元
数字。 2025 年基因组工程市场占有率（按地区）
基因组工程市场-IMG1

基因组工程，也称为基因工程，是一组允许操纵或编辑生物体基因的技术。它涉及改变生物体的基因组成，包括在物种内和跨物种引入基因，以产生改良或新的生物体。基因组工程利用 CRISPR/Cas9、TALEN、ZFN 和其他 DNA标靶化核酸酶等技术实现有针对性的基因组编辑和修改。研究人员成功地利用这些技术进行作物改良和各种生物体基因功能的实验研究。由于各行各业越来越多地采用基因组技术，全球基因组工程市场预计将会成长。

市场动态

全球基因组工程市场的成长是由基因工程在生物技术、製药和农业领域的日益广泛的应用所推动的。 CRISPR 等基因组编辑工具为研究人员提供了无与伦比的精确度，可以轻鬆改变 DNA 序列和修改基因功能，从而促进成长机会。主要企业和政府对基因组工程研究的投资增加可能会推动市场成长。然而，与人类基因编辑的安全性和伦理相关的不确定性可能会对市场进入者造成挑战。加大研发力度，开发更精确、更有效率的基因组工程工具，可望为市场成长提供新的机会。此外，环境修復和能源生产等新应用领域的开发也为不久的将来的市场成长带来了巨大的潜力。

研究的主要特点

  • 本报告对全球基因组工程市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 全球基因组工程市场的主要企业是根据公司亮点、产品系列、关键亮点、绩效和策略等参数进行的分析。
  • 其中包括的主要公司有 Thermo Fisher Scientific Inc.、CRISPR Therapeutics AG、Intellia Therapeutics, Inc.、Editas Medicine, Inc.、Sangamo Therapeutics, Inc.、Bluebird Bio, Inc.、Cellectis SA、Merck KGaA、New England Biolabs、Aanific Technologies Inc. .
  • 本报告的见解将使负责人和企业经营团队能够就未来产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球基因组工程市场迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员可以透过全球基因组工程市场分析中使用的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管情景
  • 製造商收益
  • 收购和合作场景
  • 产品发布/核准
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第 4 章。全球基因组工程市场-COVID-19 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 市场影响

5. 2020 年至 2032 年全球基因体工程市场（依技术划分）（十亿美元）

  • 介绍
  • CRISPR
  • TALEN
  • ZFN
  • 其他的

6. 2020 年至 2032 年全球基因体工程市场（按应用划分）（十亿美元）

  • 介绍
  • 细胞株工程
  • 基因工程

7. 2020 年至 2032 年全球基因体工程市场（以最终用户划分）（十亿美元）

  • 介绍
  • 生物科技和製药公司
  • 研究所
  • 合约研究组织

8. 2020 年至 2032 年全球基因体工程市场（按地区划分）（十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争格局

  • 公司简介
    • Thermo Fisher Scientific Inc.
    • CRISPR Therapeutics AG
    • Intellia Therapeutics, Inc.
    • Editas Medicine, Inc.
    • Sangamo Therapeutics, Inc.
    • Bluebird Bio, Inc.
    • Cellectis SA
    • Merck KGaA
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

第 10 章分析师建议

  • 兴衰
  • 一致的机会地图

第 11 章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1262

Global Genome Engineering Market is estimated to be valued at USD 7.70 Bn in 2025 and is expected to reach USD 20.12 Bn by 2032, growing at a compound annual growth rate (CAGR) of 14.7% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 7.70 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.70% 2032 Value Projection: USD 20.12 Bn
Figure. Genome Engineering Market Share (%), By Region 2025
Genome Engineering Market - IMG1

Genome engineering, also known as genetic engineering, is a set of technologies that enable genetic manipulation and editing of an organism's genes. It involves the alteration of an organism's genetic makeup, including the transfer of genes within and across species boundaries to produce improved or novel organisms. Genome engineering utilizes technologies such as CRISPR/Cas9, TALENs, ZFNs and other DNA targeting nucleases to enable targeted genome editing and modification. Researchers have successfully utilized these technologies for crop improvement and experimental investigation of gene function in various organisms. Global genome engineering market is expected to witness growth due to increasing adoption of genome technologies in various industries.

Market Dynamics:

Global genome engineering market growth is driven by rising application of genetic engineering in areas of biotechnology, pharmaceuticals and agriculture. Genome editing tools such as CRISPR have provided researchers unparalleled precision to easily alter DNA sequences and modify gene function, fueling growth opportunities. Growing investment by key players and governments in genome engineering-based research can drive the market growth. However, uncertainties related to safety and ethics of human gene editing can pose a challenge to market players. Increasing R&D for developing more accurate and efficient genome engineering tools is expected to offer new opportunities for the market growth. Exploration of novel applications areas such as environmental remediation and energy production also hold immense potential for market growth in the near future.

Key Features of the Study:

  • This report provides an in-depth analysis of the global genome engineering market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global genome engineering market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this Thermo Fisher Scientific Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., Editas Medicine, Inc., Sangamo Therapeutics, Inc., Bluebird Bio, Inc., Cellectis S.A., Merck KGaA, New England Biolabs, Agilent Technologies, Inc., Genscript, Synbio Technologies, Creative Biogene, Eurofins Scientific, Regeneron Pharmaceuticals Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global genome engineering market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genome engineering market.

Detailed Segmentation-

  • By Technology:
    • CRISPR
    • TALEN
    • ZFN
    • Others
  • By Application:
    • Cell Line Engineering
    • Genetic Engineering
  • By End User:
    • Biotechnology & Pharmaceutical Companies
    • Research Institutes
    • Contract Research Organizations
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific Inc.
    • CRISPR Therapeutics AG
    • Intellia Therapeutics, Inc.
    • Editas Medicine, Inc.
    • Sangamo Therapeutics, Inc.
    • Bluebird Bio, Inc.
    • Cellectis S.A.
    • Merck KGaA
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Technology
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Genome Engineering Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Genome Engineering Market, By Technology, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • CRISPR
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • TALEN
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • ZFN
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Genome Engineering Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Cell Line Engineering
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Genetic Engineering
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Genome Engineering Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020 - 2032
    • Segment Trends
  • Biotechnology & Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Research Institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Genome Engineering Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • CRISPR Therapeutics AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Intellia Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Editas Medicine, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sangamo Therapeutics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bluebird Bio, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cellectis S.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • New England Biolabs
    • Agilent Technologies, Inc.
    • Genscript
    • Synbio Technologies
    • Creative Biogene
    • Eurofins Scientific
    • Regeneron Pharmaceuticals Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact

"